LY-320,135
id:
ly-320-135-232-9355981
title:
LY-320,135
text:
LY-320,135 is a drug used in scientific research which acts as a selective antagonist of the cannabinoid receptor CB1. It was developed by Eli Lilly and Company in the 1990s. LY-320,135 displays fairly good selectivity, with a binding affinity for CB1 around 70x stronger than for CB2, but both its potency and selectivity are modest compared to newer agents, and at higher doses it also binds to a range of non-cannabinoid receptors. However LY-320,135 is still fairly widely used in research, parti
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/LY-320,135
date created:
date modified:
2024-03-23T09:40:02Z
main entity:
{"identifier":"Q6460421","url":"https://www.wikidata.org/entity/Q6460421"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b1/LY-320%2C135_Structure.svg","width":142,"height":106}
fields total:
13
integrity:
15